Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@Michigan_Value Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::1799243134838165504.png) @Michigan_Value Michigan Value Investor

Michigan Value Investor posts on X about $hrow, $275m, $hrows, $eton the most. They currently have XXXXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours.

### Engagements: XXX [#](/creator/twitter::1799243134838165504/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1799243134838165504/c:line/m:interactions.svg)

- X Week XXXXX -XX%
- X Month XXXXXX -XX%
- X Months XXXXXXX +376%
- X Year XXXXXXX +94%

### Mentions: X [#](/creator/twitter::1799243134838165504/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1799243134838165504/c:line/m:posts_active.svg)

- X Month XX -XX%
- X Months XXX +479%
- X Year XXX +140%

### Followers: XXXXX [#](/creator/twitter::1799243134838165504/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1799243134838165504/c:line/m:followers.svg)

- X Week XXXXX +2.30%
- X Month XXXXX +4.30%
- X Months XXXXX +51%
- X Year XXXXX +83%

### CreatorRank: XXXXXXXXX [#](/creator/twitter::1799243134838165504/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1799243134838165504/c:line/m:influencer_rank.svg)

### Social Influence

**Social category influence**
[finance](/list/finance) 

**Social topic influence**
[$hrow](/topic/$hrow), [$275m](/topic/$275m) #2, [$hrows](/topic/$hrows) #1, [$eton](/topic/$eton), [ceo](/topic/ceo), [eton](/topic/eton), [drugs](/topic/drugs) #48, [$240m](/topic/$240m), [$320m](/topic/$320m), [$2b](/topic/$2b)

**Top accounts mentioned or mentioned by**
[@pedrolamento](/creator/undefined) [@pythiar](/creator/undefined) [@chrisolin](/creator/undefined) [@towiu2](/creator/undefined) [@martinshkreli](/creator/undefined) [@themateuszcaban](/creator/undefined) [@apphyd](/creator/undefined) [@genejchan](/creator/undefined) [@russella1221](/creator/undefined) [@sebkrog](/creator/undefined) [@wallstpirate](/creator/undefined) [@spacinfleqtion](/creator/undefined) [@mitchmartan98](/creator/undefined) [@commonsenseplay](/creator/undefined) [@oppenheimer](/creator/undefined) [@europeandgi](/creator/undefined) [@johnhempton](/creator/undefined) [@bsgcap](/creator/undefined) [@mobst](/creator/undefined) [@lukewolgram](/creator/undefined)
### Top Social Posts
Top posts by engagements in the last XX hours

"$HROW reveals internal expectations for Lucentis/Eylea biosimilars: $240M-$320M run rate by 2H 2027 compare to total company revenue of $275M in 2025"  
[X Link](https://x.com/Michigan_Value/status/1996191577933500889)  2025-12-03T12:15Z 1355 followers, 11.9K engagements


"Deep dive on $HROW's Dry Eye Disease drug Vevye. DED market today $2B growing XX% CAGR. Why Read on. Vevye Q4 XX XX% share up from X% in Q1 about to accelerate. Why Read on. HROW 2025 revenue $275M. Vevye $100M in XX $300M in XX $2B in 2030. Why Read on"  
[X Link](https://x.com/Michigan_Value/status/1996968199812735164)  2025-12-05T15:41Z 1355 followers, 7719 engagements


"$ETON presentation today path $500M revenue. CEO underpromise/overdeliver kind of guy so far"  
[X Link](https://x.com/Michigan_Value/status/1996592019355934795)  2025-12-04T14:46Z 1355 followers, 1303 engagements


"@app_hyd $ETON spun out of $HROW yet another creation of CEO Mark Baum this time in partnership with ETON CEO Sean Brynjelsen. Deep dive:"  
[X Link](https://x.com/Michigan_Value/status/1996651380111810812)  2025-12-04T18:42Z 1353 followers, XXX engagements


"By Jan 2024 two vastly better drugs are available Miebo & Vevye. Work better faster limited side effects. DED market growing at XX% CAGR as patients return and try new drugs and many of them benefit. 2030 US DED market $6B at this pace"  
[X Link](https://x.com/Michigan_Value/status/1996968206381060370)  2025-12-05T15:41Z 1355 followers, XXX engagements


"$HROW's Vevye is the best drug. It does everything $BLCO's Miebo does & also treats inflammation which presents in almost all DED cases. Both are good drugs poor but improving insurance coverage. Coverage takes time but improves with share"  
[X Link](https://x.com/Michigan_Value/status/1996968208444600609)  2025-12-05T15:41Z 1355 followers, XXX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@Michigan_Value Avatar @Michigan_Value Michigan Value Investor

Michigan Value Investor posts on X about $hrow, $275m, $hrows, $eton the most. They currently have XXXXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours.

Engagements: XXX #

Engagements Line Chart

  • X Week XXXXX -XX%
  • X Month XXXXXX -XX%
  • X Months XXXXXXX +376%
  • X Year XXXXXXX +94%

Mentions: X #

Mentions Line Chart

  • X Month XX -XX%
  • X Months XXX +479%
  • X Year XXX +140%

Followers: XXXXX #

Followers Line Chart

  • X Week XXXXX +2.30%
  • X Month XXXXX +4.30%
  • X Months XXXXX +51%
  • X Year XXXXX +83%

CreatorRank: XXXXXXXXX #

CreatorRank Line Chart

Social Influence

Social category influence finance

Social topic influence $hrow, $275m #2, $hrows #1, $eton, ceo, eton, drugs #48, $240m, $320m, $2b

Top accounts mentioned or mentioned by @pedrolamento @pythiar @chrisolin @towiu2 @martinshkreli @themateuszcaban @apphyd @genejchan @russella1221 @sebkrog @wallstpirate @spacinfleqtion @mitchmartan98 @commonsenseplay @oppenheimer @europeandgi @johnhempton @bsgcap @mobst @lukewolgram

Top Social Posts

Top posts by engagements in the last XX hours

"$HROW reveals internal expectations for Lucentis/Eylea biosimilars: $240M-$320M run rate by 2H 2027 compare to total company revenue of $275M in 2025"
X Link 2025-12-03T12:15Z 1355 followers, 11.9K engagements

"Deep dive on $HROW's Dry Eye Disease drug Vevye. DED market today $2B growing XX% CAGR. Why Read on. Vevye Q4 XX XX% share up from X% in Q1 about to accelerate. Why Read on. HROW 2025 revenue $275M. Vevye $100M in XX $300M in XX $2B in 2030. Why Read on"
X Link 2025-12-05T15:41Z 1355 followers, 7719 engagements

"$ETON presentation today path $500M revenue. CEO underpromise/overdeliver kind of guy so far"
X Link 2025-12-04T14:46Z 1355 followers, 1303 engagements

"@app_hyd $ETON spun out of $HROW yet another creation of CEO Mark Baum this time in partnership with ETON CEO Sean Brynjelsen. Deep dive:"
X Link 2025-12-04T18:42Z 1353 followers, XXX engagements

"By Jan 2024 two vastly better drugs are available Miebo & Vevye. Work better faster limited side effects. DED market growing at XX% CAGR as patients return and try new drugs and many of them benefit. 2030 US DED market $6B at this pace"
X Link 2025-12-05T15:41Z 1355 followers, XXX engagements

"$HROW's Vevye is the best drug. It does everything $BLCO's Miebo does & also treats inflammation which presents in almost all DED cases. Both are good drugs poor but improving insurance coverage. Coverage takes time but improves with share"
X Link 2025-12-05T15:41Z 1355 followers, XXX engagements

@Michigan_Value
/creator/twitter::Michigan_Value